Harmony Biosciences Holdings (HRMY) Inventory Average (2020 - 2026)
Harmony Biosciences Holdings (HRMY) reported Inventory Average of $5.4 million for Q1 2026, down 20.47% on a YoY basis from $6.8 million in Q1 2025, and down 14.04% sequentially from $6.3 million in Q4 2025.
Harmony Biosciences Holdings (HRMY) Inventory Average (2020 - 2026) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 7 years of Inventory Average data on file, last reported at $5.4 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average fell 20.47% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (down 20.47% YoY), and the FY2025 full-year result was $6.4 million, up 1.26% from the prior year.
- Inventory Average declined to $5.4 million in Q1 2026, from $6.3 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $7.1 million in Q4 2024 to a low of $4.4 million in Q3 2022.
- A 5-year average of $5.6 million and a median of $5.4 million in 2026 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average surged 35.05% in 2024 and fell 20.47% in 2026, its largest moves.
- Tracing HRMY's Inventory Average over 5 years: stood at $4.7 million in 2022, then increased by 10.47% to $5.2 million in 2023, then surged by 35.05% to $7.1 million in 2024, then decreased by 10.95% to $6.3 million in 2025, then retreated by 14.04% to $5.4 million in 2026.
- Business Quant data shows HRMY's Inventory Average at $5.4 million in Q1 2026, $6.3 million in Q4 2025, and $6.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn | 5.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.40 Mn |
| Dec 31, 2025 | 6.28 Mn |
| Sep 30, 2025 | 6.57 Mn |
| Jun 30, 2025 | 6.24 Mn |
| Mar 31, 2025 | 6.79 Mn |
| Dec 31, 2024 | 7.06 Mn |
| Sep 30, 2024 | 6.28 Mn |
| Jun 30, 2024 | 5.75 Mn |
| Mar 31, 2024 | 5.61 Mn |
| Dec 31, 2023 | 5.23 Mn |
| Sep 30, 2023 | 4.97 Mn |
| Jun 30, 2023 | 4.78 Mn |
| Mar 31, 2023 | 4.81 Mn |
| Dec 31, 2022 | 4.73 Mn |
| Sep 30, 2022 | 4.38 Mn |
| Jun 30, 2022 | 4.63 Mn |
| Mar 31, 2022 | 4.96 Mn |
| Dec 31, 2021 | 5.06 Mn |
| Sep 30, 2021 | 5.10 Mn |
| Jun 30, 2021 | 4.83 Mn |